SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-13-002779
Filing Date
2013-07-16
Accepted
2013-07-16 15:52:01
Documents
2
Period of Report
2013-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_071613.htm 6-K 18539
2 EXHIBIT 99.1 exh_991.htm EX-99.1 29084
  Complete submission text file 0001171843-13-002779.txt   48628
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 13970399
SIC: 2834 Pharmaceutical Preparations